ITGAM and Hepatic fibrosis: Additionally, compared to the HFMCD-fed NTG mice, HTG mice also had reduced hepatic fibrosis and decreased F4/80- and CD11b-positive inflammatory cell infiltration in response to HFMCD treatment (Fig. 8g, h).